HORNER GEORGE F III 4
4 · Durata Therapeutics, Inc. · Filed Jul 26, 2012
Insider Transaction Report
Form 4
HORNER GEORGE F III
Director
Transactions
- Conversion
Common Stock
2012-07-24+56,103→ 71,728 total - Conversion
Series A Convertible Preferred Stock
2012-07-24−448,825→ 0 total→ Common Stock (56,103 underlying) - Conversion
Common Stock
2012-05-01$0.96/sh+15,625$15,000→ 15,625 total - Conversion
Stock Option (right to buy)
2012-05-01$0.96/sh−15,625$15,000→ 15,625 totalExercise: $0.96Exp: 2020-03-25→ Common Stock (15,625 underlying) - Purchase
Series A Convertible Preferred Stock
2012-03-15$1.00/sh+127,907$127,907→ 448,825 total→ Common Stock (15,988 underlying)
Footnotes (3)
- [F1]The Series A Preferred Stock had no expiration date and each share of Series A Preferred Stock converted automatically into approximately 0.125 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration.
- [F2]Reflects a one-for-8.0000 reverse stock split that became effective on July 6, 2012.
- [F3]This option was granted on March 26, 2010 with respect to 31,250 shares of Common Stock, with 25% vesting on March 1, 2011 and the remaining 75% vesting in 36 substantially equal monthly installments beginning on April 31, 2011. This option was exercised with respect to 15,625 shares of Common Stock on May 1, 2012.